To view this email as a web page, go here.

Message below is a paid advertisement. Content is provided by the sponsor.

The 12-week* difference of BRAVECTO® (fluralaner) keeps pet owners coming back to your clinic.

Satisfied clients are loyal clients. Give them the ease and efficacy they’re looking for in flea and tick treatment with BRAVECTO.

Pet owners already have a lot to remember. Give them one less thing to forget. Only BRAVECTO delivers up to 12 weeks* of flea & tick protection for dogs or cats with just one dose.

Offering the convenience and peace of mind that comes with effective, extended-duration flea and tick prevention means clients know you’re listening to their concerns and needs.

Over 89% of pet owners surveyed said prescription-only BRAVECTO was more convenient to give than monthly treatment.¹ And satisfied pet owners will come back to your clinic for their pet’s health needs and to purchase products because they see results.

That means increased profits for your clinic.

According to a study with PenBay clinic, animal hospitals that carry BRAVECTO have outpaced the sales growth of their counterparts offering alternative flea/tick monthly products.²

Talk to your Merck Animal Health Rep about how BRAVECTO can boost sales, or Visit BravoVets.com

BRAVECTO (Fluralaner) Chew or Topical Solution

BRAVECTO kills fleas and prevents flea infestations for 12 weeks. BRAVECTO Chew and BRAVECTO Topical Solution for Dogs kill ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kill lone star ticks for 8 weeks. BRAVECTO Topical Solution for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.

¹Data on file. Merck Animal Health, Madison, NJ. 2016.

²Source: GFK YTD December 2015 Same Clinic Comparison.

Important Safety Information:
BRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. BRAVECTO Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Use caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures. BRAVECTO Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving BRAVECTO, even in cats without a history of neurologic abnormalities.

View prescribing information:
BRAVECTO Chew | BRAVECTO Topical Solution for Dogs | BRAVECTO Topical Solution for Cats

If you no longer wish to receive these emails from Merck Animal Health, please unsubscribe here.

Merck Animal Health is committed to protecting your privacy. Information on the collection and use of your personal information may be viewed at www.merck.com/privacy.

This email was sent on behalf of Intervet Inc., Madison, NJ 07940 USA. US/BRV/0518/0104a